Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

75%

3 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed trials have results

Key Signals

Enrollment Performance

Analytics

Phase 4
2(66.7%)
Phase 3
1(33.3%)
3Total
Phase 4(2)
Phase 3(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT06243536Phase 4Unknown

The Effect of Semaglutide on Disordered Eating Behaviour in Type 2 Diabetic Patients

Role: collaborator

NCT04015414Phase 3Completed

Varenicline Versus Cytisine for Smoking Cessation in Primary Care Setting

Role: collaborator

NCT05307718Unknown

Pharmacogenomics in Prediction of Cardiovascular Drugs Adverse Reaction

Role: collaborator

NCT05124314Phase 4Unknown

Comparison of Two Different Drug Regimens for Medical Treatment of Early Pregnancy Loss

Role: collaborator

All 4 trials loaded